Cidara Therapeutics Inc (CDTX) Stock Analysis
Sector: HEALTHCARE - BIOTECHNOLOGY
Exchange: NASDAQ
Key Metrics
- Price: $221.38
Market Sentiment
Cidara Therapeutics Inc currently has a Bullish sentiment score of 0.23.
About Cidara Therapeutics Inc
Cidara Therapeutics, Inc. is a forward-thinking biotechnology firm headquartered in San Diego, California, focused on advancing long-acting anti-infective therapies to tackle critical unmet medical needs in infectious diseases. Utilizing its proprietary Cloudbreak™ platform, Cidara is at the forefront of developing innovative treatments that aim to improve patient outcomes and increase treatment adherence. The company's diverse pipeline encompasses promising therapeutics targeting both fungal...
GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Cidara Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.
Frequently Asked Questions
Does CDTX pay dividends?
Cidara Therapeutics Inc (CDTX) does not currently pay a regular dividend.